Illustrative image – not actual.Cadila Pharmaceuticals (CPL) is in talks with one firm each in South Korea, Japan and Indonesia, for a tie-up to manufacture auto-disposable syringes. The plant is expected to be operational by mid-2003.
Casil Health Products (CHPL), a subsidiary of CHPL plans investment of around Rs 25 crores in the proposed facility, with a capacity to produce 1 million syringes a month.
The company also intends to get a commitment from the potential partner to buy back the product. The company is also open to the idea of setting joint venture with the prospective partner.
Cadila expects to finalise the tie-up before December 2002.
